Recent advances in machine perfusion show improved graft viability and expand donor utilization, highlighting clinical implementation challenges.
This manuscript synthesizes the most recent advances in machine perfusion (MP) presented at the 2025 International Liver Transplantation Society Congress in Singapore. We highlight how MP has matured into a transformative tool in liver transplantation, with growing evidence of improved graft viability, reduced complications, expanded donor utilization, and systemic impact on allocation and logistics. Special attention is given to recent innovations in translational bridges and real‐world cost analyses that support broader clinical implementation.
No takes yet. Share an insight, caveat, or question.
Putri et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: